Metastatic Renal Cell Carcinoma Completed Phase 1 Trials for Radium Ra-223 (DB12813)

Also known as: Metastatic renal cell carcinoma (morphologic abnormality) / Metastatic renal cell carcinoma (disorder)

Indication	Status	Phase
DBCOND0030098 (Metastatic Renal Cell Carcinoma)	Completed	1

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT02406521	Exploratory Study of Radium-223 and VEGF-Targeted Therapy in Patients With Metastatic Renal Cell Carcinoma and Bone Mets	Treatment	Pazopanib (DB06589) Radium Ra 223 dichloride (DB08913) Radium Ra-223 (DB12813) Sorafenib (DB00398)